OIM
GSK icon

Orca Investment Management’s GSK GSK Stock Holding History

Orca Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-44,513
Closed -$2.4M – 72
2016
Q3 		$2.4M Sell
44,513
-298
-0.7% -$16.3K 2.5% 14
2016
Q2 		$2.43M Sell
44,811
-139
-0.3% -$7.32K 2.37% 15
2016
Q1 		$2.28M Sell
44,950
-724
-2% -$36.1K 2.57% 14
2015
Q4 		$2.3M Sell
45,674
-14
-0% -$714 2.54% 11
2015
Q3 		$2.2M Sell
45,688
-506
-1% -$26.3K 2.69% 11
2015
Q2 		$2.4M Buy
46,194
+2,227
+5% +$125K 2.22% 13
2015
Q1 		$2.54M Buy
43,967
+1,282
+3% +$73.5K 2.26% 14
2014
Q4 		$2.28M Buy
42,685
+499
+1% +$27.9K 2.03% 18
2014
Q3 		$2.42M Buy
42,186
+17,390
+70% +$1.07M 2.09% 17
2014
Q2 		$1.66M Buy
24,796
+2,846
+13% +$193K 1.31% 30
2014
Q1 		$1.47M Sell
21,950
-168
-0.8% -$11.4K 1.22% 32
2013
Q4 		$1.48M Buy
+22,118
New +$1.43M 1.2% 34

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Orca Investment Management's GSK Position: Q4 2016 in Review

Orca Investment Management sold out of GSK (GSK) in Q4 2016, closing a stake of 44,513 shares — an estimated $2.4M sold.

Orca Investment Management first reported a position in GSK in Q4 2013 and held it in 12 quarters. The position peaked at $2.54M in Q1 2015. 762 funds tracked by Wall St. Rank hold GSK as of Q4 2016.

  • Orca Investment Management reported no remaining GSK position as of Q4 2016 after selling out during the quarter.
  • Orca Investment Management sold 44,513 GSK shares in Q4 2016, an estimated $2.4M.
  • Orca Investment Management first reported a position in GSK in Q4 2013 and held it in 12 quarters.
  • Orca Investment Management's GSK position peaked at $2.54M in Q1 2015.
  • 762 funds tracked by Wall St. Rank held GSK as of Q4 2016.

Based on Orca Investment Management's 13F filing for Q4 2016, filed 26 Jan 2017.